Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.89
Oct. 04, 2024 16:00:00- Change 0 (0%)
- Volume 11,142
- Today's Open 1.86
- Previous Close 1.89
- Today's High 2
- Today's Low 1.86
- 52 Week High 4.481
- 52 Week Low 1.57